Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Evaluation of the Effect of Ketamine on Neurological Activity as Measured by Quantitative EEG

To see complete record on, please visit this link

Id: NCT05095792

Organisation Name: Entheon Biomedical Corp.

Overal Status: Completed

Start Date: November 9, 2021

Last Update: November 7, 2022

Lead Sponsor: Entheon Biomedical Corp.

Brief Summary: This observational study will allow data to be collected to demonstrate changes in brain activity following administration of standard of care (SOC) Ketamine. By comparing genetic markers across participants, data on impact of genetic markers and response to Ketamine will also be analysed. This data will contribute to the design of future studies utilizing Ketamine for various psychiatric disorders. This study will focus on treatment-resistant Major Depressive Disorder (MDD).

  • Treatment-resistant Depression

Total execution time in seconds: 0.3844850063324